维普中文期刊产品整合服务
111篇 您的检索式:作者名="Roehrbom"
    题名 作者 年代 出处 被引量
1The long-term effect of doxazosin,Finasteride,and combination therapy on the clinieal progression of benign prostatic hyperplasia显示文摘McConnell JD Roehrbom CG Bautista OM 2003N Engl J Med2003,349,:1
2Serum prostate-specefic antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia PLESS Study Group显示文摘Roehrbom CG Mc Connell JD Lieber M 1999Urology1999,53,3:1
3Male lower urinary tract symptoms(LUST) and benign prostatic hyperplasia ( BPH ) 显示文摘Roehrbom CG 2011Med Clin North Am2011,95,1:1
4The clinical benefits of dutasteride treatment for LUTS and BPH显示文摘Roehrbom CG 2004Rev Urol2004,6,9:1
5Cost comparison for laparoseopie nephreetomy and open nephreetomy: analysis of individual parameters显示文摘Lotan Y Gettman MT Roehrbom CG 2002Urol2002,59,6:1
6Early postoperative plasma transforming growth factor - β1 is a strong predictor of biochemical progression afer radical prostatectomy 显示文摘Shariat SF Walz J Roehrbom CG 2008J Urol2008,179,:1
7Urinary retention in patients with BPH treated with finasteride or placebo 4 years显示文摘Roehrbom CG Bruskewity R Nickel GC 2000Eur Urol2000,37,5:1
8Benign prostate hyperplasia:an overview 显示文摘Claus G Roehrbom MD 2005Rev Urol2005,7,9:1
9An updatedcatalog of prostate cancer predictive tools 显示文摘Shariat SF Karakiewicz PI Roehrbom CG 2008Cancer2008,113,:1
10Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis显示文摘Shariat SF Roehrbom CG McConnell JD 2007J Clin Oncol2007,25,4:1
11The long-term effect of doxazosin, finastetide, and combination therapy on the clinical progression of benigh prostatic hype rplasia 显示文摘Mcconnell JD Roehrbom CG Bautista OM 2003N Engl J Med2003,349,:1
12The long-term effect of doxazosin,finasteride,and combination therapy on the clinical progression of benign prostatic hyperplasia显示文摘McConnell JD Roehrbom CG Bausfita OM 2003N Engl J Med2003,349,:1
13The relationship be- tween symptoms of prestatitis and histologic inflammation: Examina- tion of baseline data from the REDUCE chemoprevention trial 显示文摘Nickel JC Roehrbom CG Oleary MP 2007Uro12007,178,3:1
14The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the Comb AT study显示文摘ROEHRBOM CG SIAMI P BARKIN J 2010Eur Urol2010,57,1:1
15Effect of dutas- teride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the comb AT trial显示文摘BARKIN J ROEHRBOM CG SIAMI P 2009BJU Int2009,103,7:1
16BPH progression:concept and key Learning from MTops,ALTESS, COMBAT, and ALF-ONE 显示文摘Roehrbom CG 2008BLU Int2008,,:1
17Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either mono therapy in men with benign prostatic hyperplasia (BPH)by base- lineeharaeteristics : 4 -year results from the randomized, double - blind Combination of Avodart and Tamsulosin (CombAT)trial显示文摘Roehrbom CG Barkin J Siami P 2011BJU international2011,107,6:1
18The long-ter-meffect of doxazosin and combination therapy on the clinical pro-gression ofbenign prostatic hyperplasia显示文摘Mc Connell JD Roehrbom CG Baustita OM 2003N Engl J Med2003,349,:1
19Association of the circulating levels of theurokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis 显示文摘Shariat SF Roehrbom CG McConnell JD 2007J Clin Oncol2007,25,4:1
20Examination of the relationship between symptoms of prostatitis and histo- logical inflammation : baseline data from the REDUCE che- moprevention trial显示文摘Nickel JC Roehrbom CG O'Ieary MP 2007J Urol2007,178,31:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费